Attovia Therapeutics, Inc.
ATTO
IPO
$22.86
-$0.80-3.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -20.69M | -18.66M | -14.44M | ||
| Total Depreciation and Amortization | 246.00K | 242.00K | 207.00K | ||
| Total Amortization of Deferred Charges | -- | -- | 29.00K | ||
| Total Other Non-Cash Items | 1.01M | 814.00K | 110.00K | ||
| Change in Net Operating Assets | 2.64M | -541.00K | 1.53M | ||
| Cash from Operations | -16.79M | -18.14M | -12.57M | ||
| Capital Expenditure | -73.00K | -288.00K | -94.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 6.95M | 22.77M | -74.07M | ||
| Cash from Investing | 6.88M | 22.49M | -74.17M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 31.00K | 11.00K | 98.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | 0.00 | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -587.00K | -1.25M | -26.00K | ||
| Cash from Financing | -556.00K | -1.24M | 72.00K | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -10.47M | 3.10M | -86.66M | ||